-
My Account
In App
My Account
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 2 | 1747.65 | 1750.00 | 5 |
| 1 | 1747.60 | 1750.55 | 1 |
| 1 | 1747.55 | 1750.95 | 1 |
| 1 | 1747.50 | 1751.00 | 8 |
| 1 | 1747.45 | 1751.15 | 1 |
| 9447 | Total | Total | 3486 |
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 2 | 1747.65 | 1750.00 | 5 |
| 1 | 1747.60 | 1750.55 | 1 |
| 1 | 1747.55 | 1750.95 | 1 |
| 1 | 1747.50 | 1751.00 | 8 |
| 1 | 1747.45 | 1751.15 | 1 |
| 9447 | Total | Total | 3486 |
| Open | 1,730.00 |
| Previous Close | 1,734.90 |
| Volume | 41,738.00 |
| Value (Lacs) | 730.42 |
| VWAP | 1,740.99 |
| Beta | |
| Mkt Cap (Rs. Cr.) | 28,832 |
| High | 1,752.00 |
| Low | 1,718.00 |
| UC Limit | 2,081.80 |
| LC Limit | 1,388.00 |
| 52 Week High | 2,131.00 |
| 52 Week Low | 1,277.80 |
| Face Value | 1.00 |
| All Time High | 4,350.00 |
| All Time Low | 861.00 |
| 20D Avg Volume | 421,923 |
| 20D Avg Delivery(%) | 29.26 |
| Book Value Per Share | 555.41 |
| Dividend Yield | 1.03 |
| TTM EPS See historical trend | 47.97 (+4.85% YoY) |
| TTM PE See historical trend | 36.48 (Low PE) |
| P/B See historical trend | 3.16 (Low P/B) |
| Sector PE | 40.19 |
*Delayed by 20 seconds.
Stock Score
Get detailed analysis with Moneycontrol Stock Insights.
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Moving Averages | -- |
| Technical Indicators | -- |
| Moving Averages Crossovers | -- |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
4 out of 6 years Gland Pharma has given positive returns in December.
| Month | Max. Positive Change(%) | Avg. Positive Change(%) | Max. Negative Change(%) | Avg. Negative Change(%) | Average Change(%) |
|---|---|---|---|---|---|
| December | 10.73% (2020) | 7.33% | -11.41% (2022) | -5.98% | 2.90% |
Buy Gland Pharma; target of Rs 2310: Motilal Oswal Nov 04 2025 06:01 PM
Gland Consolidated September 2025 Net Sales at Rs 1,486.88 crore, up 5.76% Y-o-Y Nov 04 2025 09:32 AM
Stocks to Watch Today: Bharti Airtel, Titan, SJS Enterprises, Godfrey Phillips, Hitachi Energy, Hero Moto, Cipla, City Union Bank in focus on 04 November Nov 04 2025 04:01 AM
Gland Pharma net profit rises 12%YoY to Rs 183.7 crore in Q2FY26 Nov 03 2025 09:44 PM
Posted by : The Fixed Income
Repost this message
Lock in a Steady 9.15% from a Trusted NBFC Bond 9.15% VIVRITI CAPITAL LIMITED 2027 ✔️ Coupon: 9.15% ✔️ Rating: CARE A+ Stable ✔️ Tenor: 1y 10m (Maturity: 04 Nov 2027) Senior Secured | High-Return | NBFC Bond | Listed Add a reliable, secured NBFC bond to your portfolio and benefit from consistent yields with medium-term tenure. ???? Explore on The Fixed Income: https://www.thefixedincome.com/product/dVJDc1lRPT0=/1060-navi-finserv-limited-2027?utm_source=Moneycontrol&utm_medium=Forum&utm_campaign=Product_list
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 1016219 | Price 1588.69 | % Traded 0.62 |
| Qty 838556 | Price 1588.69 | % Traded 0.51 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Gland | 1,749.60 | 0.85 | 28,825.78 | 24.93 | 2.95 | 11.17 | -4.61 | 1,089 | 4,116 | 0.00 |
| Sun Pharma | 1,806.30 | -0.66 | 433,391.88 | 41.48 | 6.00 | 15.13 | -0.39 | 10,980 | 52,578 | 0.03 |
| Divis Labs | 6,444.00 | -0.39 | 171,067.95 | 68.84 | 11.43 | 14.63 | 5.71 | 2,191 | 9,360 | 0.00 |
| Torrent Pharma | 3,794.70 | -0.03 | 128,429.89 | 60.01 | 17.11 | 25.17 | 12.89 | 1,911 | 11,516 | 0.40 |
| Cipla | 1,520.50 | -0.03 | 122,821.61 | 22.57 | 3.94 | 16.90 | 1.49 | 5,291 | 27,547 | 0.00 |
Sharpest Opinions & Actionable Insights 
Exclusive Webinars 
Research & Expert Technical Analysis 
